0001209191-14-075849.txt : 20141216
0001209191-14-075849.hdr.sgml : 20141216
20141216161437
ACCESSION NUMBER: 0001209191-14-075849
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141212
FILED AS OF DATE: 20141216
DATE AS OF CHANGE: 20141216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141289803
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-12
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2014-12-12
4
G
0
2500
0.00
D
267694
D
Common Stock
2014-12-15
4
S
0
13021
113.19
D
254673
D
Common Stock
2014-12-15
4
S
0
15440
114.21
D
239233
D
Common Stock
2014-12-15
4
S
0
6406
115.05
D
232827
D
Common Stock
2014-12-15
4
S
0
3400
116.27
D
229427
D
Common Stock
2014-12-15
4
S
0
8650
117.26
D
220777
D
Common Stock
2014-12-15
4
S
0
2700
118.05
D
218077
D
Common Stock
2014-12-15
4
S
0
200
119.00
D
217877
D
Common Stock
2014-12-15
4
S
0
200
120.17
D
217677
D
Common Stock
440
I
401(k)
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Represents a gift made to a charitable donor-advised fund.
Open market sales reported on this line occurred at a weighted average price of $113.19 (range $112.66 to $113.65).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $114.21 (range $113.66 to $114.65).
Open market sales reported on this line occurred at a weighted average price of $115.05 (range $114.69 to $115.68).
Open market sales reported on this line occurred at a weighted average price of $116.27 (range $115.73 to $116.70).
Open market sales reported on this line occurred at a weighted average price of $117.26 (range $116.74 to $117.73).
Open market sales reported on this line occurred at a weighted average price of $118.05 (range $117.74 to $118.64).
Kenneth L. Horton, Attorney-In-Fact
2014-12-16